Growth Metrics

Opus Genetics (IRD) Profit After Tax Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 65.80%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.05%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -290.15%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 59.59%
7 Evaxion A 62.56 Bn 62.54 Bn - -129.68%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,228.66%
10 Opus Genetics 357.99 Mn 298.03 Mn - -699.79%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -699.79%
Dec 31, 2025 52.97%
Sep 30, 2025 -131.92%
Jun 30, 2025 4.44%
Mar 31, 2025 -15.31%
Dec 31, 2024 -632.74%
Sep 30, 2024 -235.34%
Jun 30, 2024 -56.52%
Mar 31, 2024 -22.71%
Dec 31, 2023 -114.13%
Sep 30, 2023 222.73%
Jun 30, 2023 -0.69%
Mar 31, 2023 12.19%
Dec 31, 2022 637.64%
Sep 30, 2022 -7.12%
Jun 30, 2022 30.96%
Mar 31, 2022 83.10%
Dec 31, 2021 66.20%
Sep 30, 2021 -238.94%
Jun 30, 2021 -344.89%
Mar 31, 2021 -1,163.41%
Dec 31, 2020 -3,226.31%
Sep 30, 2020 36.30%
Jun 30, 2020 34.91%
Mar 31, 2020 -31.80%
Dec 31, 2019 119.17%
Sep 30, 2019 63.30%
Jun 30, 2019 35.80%
Mar 31, 2019 -12.92%
Dec 31, 2018 13.25%
Sep 30, 2018 -414.30%
Jun 30, 2018 -505.28%
Mar 31, 2018 90.40%
Dec 31, 2017 -583.65%
Sep 30, 2017 63.79%
Jun 30, 2017 153.63%
Mar 31, 2017 -420.87%
Dec 31, 2016 81.58%
Sep 30, 2016 28.80%
Jun 30, 2016 45.40%
Mar 31, 2016 2.87%
Dec 31, 2015 -29.05%
Sep 30, 2015 -111.32%
Jun 30, 2015 -1,763.12%
Mar 31, 2015 70.74%
Dec 31, 2014 18.74%
Sep 30, 2014 11.00%
Jun 30, 2014 106.26%
Mar 31, 2014 -854.22%
Dec 31, 2013 -4,808.79%
Sep 30, 2013 28.38%
Jun 30, 2013 -198.23%
Mar 31, 2013 28.49%
Dec 31, 2012 -114.23%
Sep 30, 2012 -103.45%
Jun 30, 2012 82.12%
Mar 31, 2012 51.76%
Dec 31, 2011 114.91%
Sep 30, 2011 -771.21%
Jun 30, 2011 -62.04%